BBS-Bioactive Bone Substitutes
Defunct1 known investors
Find your way into BBS-Bioactive Bone Substitutes
Sign up to see every warm intro you have to BBS-Bioactive Bone Substitutes
- Paths you didn't know you had: your email and LinkedIn already hold routes to the BBS-Bioactive Bone Substitutes team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
BBS-Bioactive Bone Substitutes was a Finnish biomedical company that developed and sold ARTEBONE, a tricalcium-phosphate bone-graft substitute for treating bone defects.
Investors · 1
In the news
Frequently asked questions
- What does BBS-Bioactive Bone Substitutes do?
- BBS-Bioactive Bone Substitutes was a Finnish biomedical company that developed and sold ARTEBONE, a tricalcium-phosphate bone-graft substitute for treating bone defects.
- Who are BBS-Bioactive Bone Substitutes's investors?
- BBS-Bioactive Bone Substitutes's investors include Innovestor Ventures.